Gewurz, Benjamin E.

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Gu, S. S., Zhang, W., Wang, X., Jiang, P., Traugh, N., Li, Z., Meyer, C., Stewig, B., Xie, Y., Bu, X., et al. (2021) · Cancer Discovery

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 273

Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation

Wang, L. W., Shen, H., Nobre, L., Ersing, I., Paulo, J. A., Trudeau, S., Wang, Z., Smith, N. A., Ma, Y., Reinstadler, B., et al. (2019) · Cell Metabolism

Viral-associated cancers and disordersCancer, Hypoxia, and Metabolism

Cited by 190

Genome-wide siRNA screen for mediators of NF-κB activation

Gewurz, B. E., Towfic, F., Mar, J. C., Shinners, N. P., Takasaki, K., Zhao, B., Cahir-McFarland, E. D., Quackenbush, J., Xavier, R. J., & Kieff, E. (2012) · Proceedings of the National Academy of Sciences

NF-κB Signaling PathwaysSignaling Pathways in Disease

Cited by 108

The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane

Wang, Y., Liao, Y., Sun, Y., Mitra, B., Guo, R., Piedras, B. I., White, S., Tang, H.-Y., Asara, J. M., Tempera, I., et al. (2025) · Nature Communications

PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy

Cited by 7

The CTLH Ubiquitin Ligase Substrates ZMYND19 and MKLN1 Negatively Regulate mTORC1 at the Lysosomal Membrane

Wang, Y., Guo, R., Piedras, B. I., Tang, H.-Y., Asara, J. M., Tempera, I., Lieberman, P. M., & Gewurz, B. E. (2024) · Nature Communications

PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy

Cited by 7

Multi-omics profiling of primary human B cells activated via distinct stimuli

Aguiar, V. R. C., Franco, M. E., Abdel Aziz, N., Fernandez-Salinas, D., Chiñas, M., Colantuoni, M., Xiao, Q., Hackert, N., Liao, Y., Cervantes-Diaz, R., et al. (2026) · Nature Communications

T-cell and B-cell ImmunologyGenomics and Chromatin Dynamics

Cited by 0